The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022

被引：49
|
作者：
Pang, Xiaojing [1 ]
Liu, Yang [1 ]
Li, Hua [1 ,2 ]
Chen, Lixia [1 ]
机构：
[1] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Key Lab Struct Based Drug Design & Discovery, Minist Educ, Shenyang 110016, Peoples R China
[2] Fujian Univ Tradit Chinese Med, Inst Struct Pharmacol & TCM Chem Biol, Coll Pharm, Fuzhou 350122, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 257卷
基金：
中国国家自然科学基金;
关键词：
COVID-19; SARS-CoV-2; M pro inhibitors; Drug repurposing; Drug design; COVALENT INHIBITORS; GENOME SEQUENCE; ACHILLES-HEEL; CORONAVIRUS; DISCOVERY; EBSELEN; IDENTIFICATION; REPLICATION; DESIGN; 3C;
D O I：
10.1016/j.ejmech.2023.115491
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. The main protease (Mpro) of SARS-CoV-2 plays a central role in viral replication and transcription and represents an attractive drug target for fighting COVID-19. Many SARS-CoV-2 Mpro inhibitors have been reported, including covalent and noncovalent inhibitors. The SARS-CoV-2 Mpro inhibitor PF-07321332 (Nirmatrelvir) designed by Pfizer has been put on the market. This paper briefly introduces the structural characteristics of SARS-CoV-2 Mpro and summarizes the research progress of SARS-CoV-2 Mpro inhibitors from the aspects of drug repurposing and drug design. These information will provide a basis for the drug development of treating the infection of SARS-CoV-2 and even other coronaviruses in the future.
引用
收藏
页数：20
相关论文
共 50 条
  • [21] De novo Design of SARS-CoV-2 Main Protease Inhibitors
    Fischer, Christian
    Veprek, Nynke A.
    Peitsinis, Zisis
    Ruhmann, Klaus-Peter
    Yang, Chao
    Spradlin, Jessica N.
    Dovala, Dustin
    Nomura, Daniel K.
    Zhang, Yingkai
    Trauner, Dirk
    SYNLETT, 2022, 33 (05) : 458 - 463
  • [22] Plant protease inhibitors against SARS-CoV-2 main protease: an in silico approach
    Lima, Adrianne M.
    de Souza, Adson A.
    Amaral, Jackson L.
    Freire, Valder N.
    Souza, Pedro F.
    de Oliveira, Hermogenes D.
    FUTURE VIROLOGY, 2023, 18 (07) : 439 - 454
  • [23] Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV-2 Mpro)
    Azevedo, Pedro Henrique R. de A.
    Camargo, Priscila G.
    Constant, Larissa E. C.
    Costa, Stephany da S.
    Silva, Celimar Sinezia
    Rosa, Alice S.
    Souza, Daniel D. C.
    Tucci, Amanda R.
    Ferreira, Vivian N. S.
    Oliveira, Thamara Kelcya F.
    Borba, Nathalia R. R.
    Rodrigues, Carlos R.
    Albuquerque, Magaly G.
    Dias, Luiza R. S.
    Garrett, Rafael
    Miranda, Milene D.
    Allonso, Diego
    Lima, Camilo Henrique da S.
    Muri, Estela Maris F.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] SARS-CoV-2 Main Protease as Target
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (06) : 1278 - 1278
  • [25] Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study
    Refaey, Rana H.
    El-Ashrey, Mohamed K.
    Nissan, Yassin M.
    VIROLOGY, 2021, 554 : 48 - 54
  • [26] Optimization of the expression of the main protease from SARS-CoV-2
    Rong, Yi
    Zhang, Chaofeng
    Gao, Wen-Chao
    Zhao, Cheng
    PROTEIN EXPRESSION AND PURIFICATION, 2023, 203
  • [27] Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
    Baev, Dmitry S.
    Blokhin, Mikhail E.
    Chirkova, Varvara Yu.
    Belenkaya, Svetlana V.
    Luzina, Olga A.
    Yarovaya, Olga I.
    Salakhutdinov, Nariman F.
    Shcherbakov, Dmitry N.
    MOLECULES, 2023, 28 (01):
  • [28] Potential Self-Peptide Inhibitors of the SARS-CoV-2 Main Protease
    Banerjee, Arkadeep
    Gosavi, Shachi
    JOURNAL OF PHYSICAL CHEMISTRY B, 2023, 127 (04): : 855 - 865
  • [29] Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors
    Khatua, Kaustav
    Alugubelli, Yugendar R.
    Yang, Kai S.
    Vulupala, Veerabhadra R.
    Blankenship, Lauren R.
    Coleman, Demonta
    Atla, Sandeep
    Chaki, Sankar P.
    Geng, Zhi Zachary
    Xiao, Jing
    Chen, Peng-Hsun
    Cho, Chia-Chuan D.
    Sharma, Shivangi
    Vatansever, Erol C.
    Ma, Yuying
    Yu, Ge
    Neuman, Benjamin W.
    Xu, Shiqing
    Liu, Wenshe Ray
    ANTIVIRAL RESEARCH, 2024, 225
  • [30] Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
    Zhang, Wenfa
    Lin, Sheng-Xiang
    VIRUSES-BASEL, 2023, 15 (02):
12345